These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10971171
1. Loss of heterozygosity on the short arm of chromosome 3 in renal cancer. Maestro ML, del Barco V, Sanz-Casla MT, Moreno J, Adrover E, Izquierdo L, Zanna I, Fernández C, Redondo E, Blanco J, Resel L. Oncology; 2000 Aug; 59(2):126-30. PubMed ID: 10971171 [Abstract] [Full Text] [Related]
2. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB, Amare Kadam PS. Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [Abstract] [Full Text] [Related]
3. [The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma]. Maestro de las Casas ML, del Barco Barriuso V, Moreno Sierra J, Izquierdo López L, Sanz Casla MT, Zanna I, Redondo González E, Chicharro Almarza J, Fernández Pérez C, Resel Estévez L. Arch Esp Urol; 1999 Oct; 52(1):3-9. PubMed ID: 10101881 [Abstract] [Full Text] [Related]
4. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Velickovic M, Delahunt B, Störkel S, Grebem SK. Cancer Res; 2001 Jun 15; 61(12):4815-9. PubMed ID: 11406557 [Abstract] [Full Text] [Related]
5. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Martinez A, Fullwood P, Kondo K, Kishida T, Yao M, Maher ER, Latif F. Mol Pathol; 2000 Jun 15; 53(3):137-44. PubMed ID: 10897333 [Abstract] [Full Text] [Related]
6. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD. Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412 [Abstract] [Full Text] [Related]
7. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms. el-Naggar AK, Batsakis JG, Wang G, Lee MS. Diagn Mol Pathol; 1993 Dec 15; 2(4):269-76. PubMed ID: 7906993 [Abstract] [Full Text] [Related]
10. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion]. Tang XL, Yao GY, Chen LR, Yang ZR, Li SL. Zhonghua Wai Ke Za Zhi; 2006 Oct 01; 44(19):1314-7. PubMed ID: 17217815 [Abstract] [Full Text] [Related]
11. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Chung TK, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HK, Wong YF. Cancer Lett; 2000 Jun 30; 154(2):189-94. PubMed ID: 10806307 [Abstract] [Full Text] [Related]
12. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1). Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J. Hum Genet; 2003 Feb 30; 112(2):178-85. PubMed ID: 12522559 [Abstract] [Full Text] [Related]
13. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Br J Cancer; 1998 Feb 30; 77(2):192-200. PubMed ID: 9460988 [Abstract] [Full Text] [Related]
14. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes. Hughson MD, Meloni A, Dougherty S, Silva FG, Sandberg AA. Cancer Genet Cytogenet; 1996 Apr 30; 87(2):133-9. PubMed ID: 8625259 [Abstract] [Full Text] [Related]
15. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients]. Zhang H, Li Z, Chen M, Zhang G, Xu K. Zhonghua Fu Chan Ke Za Zhi; 2002 May 30; 37(5):298-300. PubMed ID: 12133406 [Abstract] [Full Text] [Related]
16. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Maitra A, Wistuba II, Washington C, Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF, Minna JD. Am J Pathol; 2001 Jul 30; 159(1):119-30. PubMed ID: 11438460 [Abstract] [Full Text] [Related]
17. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, Goellner JR, Grant CS, Jenkins RB, Eberhardt NL. J Clin Endocrinol Metab; 1997 Nov 30; 82(11):3684-91. PubMed ID: 9360526 [Abstract] [Full Text] [Related]
18. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder]. Xiao Z, Zhang J, Zheng S, Li C, He Z, Cheng S, Gao Y. Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1375-7. PubMed ID: 12509916 [Abstract] [Full Text] [Related]
19. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma]. Maestro ML, Izquierdo L, Sánchez-Pernaute A, Sanz Casla MT, González S, Torres A, del Barco V, Gómez A, Pérez Aguirre E, Balibrea JL. Med Clin (Barc); 1999 Apr 24; 112(14):527-9. PubMed ID: 10363238 [Abstract] [Full Text] [Related]
20. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM. Cancer Res; 1999 May 01; 59(9):2182-9. PubMed ID: 10232606 [Abstract] [Full Text] [Related] Page: [Next] [New Search]